FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,454 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Exchange Select Powder Fresh Deodorantaluminum zirconium pentachlorohydrex gly | Aluminum zirconium pentachlorohydrex gly 180 mg/g | StickTopical | Army & Air Force Exchange Service | OTC monograph drug | 55301-222 | 55301-0222-73 | — |
| Exchange Select Powder Fresh Deodorantaluminum zirconium pentachlorohydrex gly | Aluminum zirconium pentachlorohydrex gly 180 mg/g | StickTopical | Longway Technology(Guangzhou)Co., Ltd. | OTC monograph drug | 85161-222 | 85161-0222-73 | — |
| Exchange Select Shower Fresh Deodorantaluminum zirconium pentachlorohydrex gly | Aluminum zirconium pentachlorohydrex gly 180 mg/g | StickTopical | Army & Air Force Exchange Service | OTC monograph drug |
| 55301-221 |
| 55301-0221-73 |
| — |
| Exchange Select Shower Fresh Deodorantaluminum zirconium pentachlorohydrex gly | Aluminum zirconium pentachlorohydrex gly 180 mg/g | StickTopical | Longway Technology(Guangzhou) Co., Ltd | OTC monograph drug | 85161-221 | 85161-0221-73 | — |
|---|
| Exchange Select Sport Sunscreen Continuous SPF 30avobenzone, homosalate, octisalate, octocrylene | Avobenzone 30 mg/g + 3 more ingredients | SprayTopical | Army & Air Force Exchange Service | OTC monograph drug | 55301-022 | 55301-0022-37 | — |
|---|
| Exchange Select Sport Sunscreen Continuous SPF 50avobenzone, homosalate, octisalate, octocrylene | Avobenzone 30 mg/g + 3 more ingredients | SprayTopical | Army & Air Force Exchange Service | OTC monograph drug | 55301-042 | 55301-0042-63 | — |
|---|
| Exchange Select Sport Sunscreen Continuous SPF 70avobenzone, homosalate, octisalate, octcrylene | Octisalate 50 mg/g + 3 more ingredients | SprayTopical | Army & Air Force Exchange Service | OTC monograph drug | 55301-041 | 55301-0041-37 | — |
|---|
| exchange select stool softenerdocusate sodium | Docusate sodium 100 mg/1 | Capsule, Liquid filledOral | Army & Air Force Exchange Service | OTC monograph drug | 55301-486 | 55301-0486-78 | — |
|---|
| Exchange Select triple antibioticbacitracin zinc, neomycin, polymyxin b | Bacitracin zinc 400 [USP'U]/g + 2 more ingredients | OintmentTopical | Army & Air Force Exchange Service | OTC monograph drug | 55301-067 | 55301-0067-64 | — |
|---|
| exchange select Ultra Strength Antacid Assorted Fruitcalcium carbonate | Calcium carbonate 1000 mg/1 | Tablet, ChewableOral | ARMY AND AIR FORCE EXCHANGE SERVICE | OTC monograph drug | 55301-203 | 55301-0203-13 | — |
|---|
| Excitathyrotemiodium, kali iodatum, hypothalamus suis, hypophysis suis, thyroidinum (suis), lithium muriaticum, ephedra vulgaris | Iodine 9 [hp_X]/mL + 6 more ingredients | LiquidOral | Nucleic Products, LLC | Unapproved homeopathic | 75053-0004 | 75053-0004-01 | — |
|---|
| Exdensurdepemokimab | Depemokimab 100 mg/mL | Injection, SolutionSubcutaneous | GlaxoSmithKline LLC | BLA | 0173-0927 | 00173-0927-4200173-0927-61 | — |
|---|
| Exel Clarifying Line Daily Fluid Sun Shield Walnut Brown Color Broad Spectrum SPF 60 Plusoctocrylene, octinoxate, octisalate, titanium dioxide, ensulizole | Titanium dioxide 5 g/100mL + 4 more ingredients | CreamTopical | Exelencia importers Corp. | OTC monograph drug | 53863-005 | 53863-0005-01 | — |
|---|
| Exel Clarifying Line Daily Fluid Sun Shield Walnut Brown Color Broad Spectrum SPF 60 Plusoctocrylene, octinoxate, octisalate, titanium dioxide, ensulizole | Octocrylene 10 g/100mL + 4 more ingredients | CreamTopical | Biocosmetica Exel Argentina SRL | OTC monograph drug | 67623-005 | 67623-0005-01 | — |
|---|
| Exel Clarifying Line Daily Fluid Sun Shield white color Broad Spectrum SPF 60 plusoctocrylene, octinoxate, octisalate, titanium dioxide, ensulizole | Octocrylene 10 g/100mL + 4 more ingredients | CreamTopical | Exelencia importers Corp. | OTC monograph drug | 53863-004 | 53863-0004-01 | — |
|---|
| Exel Clarifying Line Daily Fluid Sun Shield White Color Broad Spectrum SPF 60 Plusoctocrylene, octinoxate, octisalate, titanium dioxide, ensulizole | Ensulizole 4 g/100mL + 4 more ingredients | CreamTopical | Biocosmetica Exel Argentina SRL | OTC monograph drug | 67623-004 | 67623-0004-01 | — |
|---|
| Exel Clarifying Line SPF 50octinoxate, octocrylene, oxybenzone, tatanium dioxide | Octinoxate 7.5 g/100mL + 3 more ingredients | CreamTopical | Exelencia importers | OTC monograph drug | 53863-125 | 53863-0125-02 | — |
|---|
| Exel Clarifying Line SPF 50octinoxate, octocrylene, oxybenzone, tatanium dioxide | Octinoxate 7.5 g/100mL + 3 more ingredients | CreamTopical | Biocosmetica Exel Argentina SRL | OTC monograph drug | 67623-001 | 67623-0001-02 | — |
|---|
| Exeldermsulconazole nitrate | Sulconazole nitrate 10 mg/g | CreamTopical | Journey Medical Corporation | NDA | 69489-711 | 69489-0711-60 | — |
|---|
| Exeldermsulconazole nitrate | Sulconazole nitrate 10 mg/mL | SolutionTopical | Journey Medical Corporation | NDA | 69489-721 | 69489-0721-30 | — |
|---|
| Exelonrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Novartis Pharmaceuticals Corporation | NDA | 0078-0501 | 00078-0501-15 | — |
|---|
| Exelonrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Novartis Pharmaceuticals Corporation | NDA | 0078-0502 | 00078-0502-15 | — |
|---|
| Exelonrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Novartis Pharmaceuticals Corporation | NDA | 0078-0503 | 00078-0503-15 | — |
|---|
| Exelonrivastigmine | Rivastigmine 4.6 mg/24h | Patch, Extended releaseTransdermal | Sandoz Inc | NDA | 66758-142 | 66758-0142-31 | — |
|---|
| Exelonrivastigmine | Rivastigmine 9.5 mg/24h | Patch, Extended releaseTransdermal | Sandoz Inc | NDA | 66758-143 | 66758-0143-31 | — |
|---|
| Exelonrivastigmine | Rivastigmine 13.3 mg/24h | Patch, Extended releaseTransdermal | Sandoz Inc | NDA | 66758-144 | 66758-0144-31 | — |
|---|
| ExEm Foamair polymer-type a intrauterine foam | — | KitIntrauterine | GISKIT PHARMA B.V. | NDA | 73254-310 | 73254-0310-01 | — |
|---|
| Exemax Creamdimethicone, allantoin | Allantoin 2 g/100g; Dimethicone 5 g/100g | CreamTopical | PureTek Corporation | OTC monograph drug | 59088-212 | 59088-0212-07 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | TabletOral | Upsher-Smith Laboratories, Inc. | ANDA | 0832-0595 | 00832-0595-30 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | Breckenridge Pharmaceutical, Inc. | ANDA | 51991-005 | 51991-0005-90 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | Aurobindo Pharma Limited | ANDA | 59651-516 | 59651-0516-30 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Sugar coatedOral | Mylan Pharmaceuticals Inc. | NDA authorized generic | 59762-2858 | 59762-2858-01 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | Bryant Ranch Prepack | ANDA | 63629-2056 | 63629-2056-01 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | ANDA | 68382-383 | 68382-0383-06 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | TabletOral | Cipla USA Inc. | ANDA | 69097-316 | 69097-0316-02 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, CoatedOral | OPKO Pharmaceuticals, LLC | ANDA | 70301-2017 | 70301-2017-01 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | TabletOral | Zydus Lifesciences Limited | ANDA | 70771-1374 | 70771-1374-03 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | Florida Pharmaceutical Products, LLC | ANDA | 71921-190 | 71921-0190-33 | — |
|---|
| Exemestane | Exemestane 25 mg/1 | Tablet, Film coatedOral | NorthStar Rx LLC | ANDA | 72603-329 | 72603-0329-01 | — |
|---|
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | ANDA | 70121-1685 | 70121-1685-01 | — |
|---|
| Exenatide | Exenatide 250 ug/mL | InjectionSubcutaneous | Amneal Pharmaceuticals LLC | ANDA | 70121-1686 | 70121-1686-01 | — |
|---|
| Exfo Tonic Acne Treatmentsalicylic acid | Salicylic acid 2 g/100mL | SolutionTopical | CONTROL CORRECTIVE SKINCARE INC | OTC monograph drug | 70764-104 | 70764-0104-51 | — |
|---|
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 5 mg/1; Valsartan 160 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0488 | 00078-0488-15 | — |
|---|
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 10 mg/1; Valsartan 160 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0489 | 00078-0489-15 | — |
|---|
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 5 mg/1; Valsartan 320 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0490 | 00078-0490-15 | — |
|---|
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 10 mg/1; Valsartan 320 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0491 | 00078-0491-15 | — |
|---|
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0559 | 00078-0559-15 | — |
|---|
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 5 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0560 | 00078-0560-15 | — |
|---|
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 10 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0561 | 00078-0561-15 | — |
|---|
| Exforge HCTamlodipine valsartan and hydrochlorothiazide | Amlodipine besylate 10 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | NDA | 0078-0562 | 00078-0562-15 | — |
|---|